# Respiratory Cathepsins, Proteases Inhibitors and Glycosaminoglycans (GAG) in Mucopolysaccharidosis

> **NCT04112602** · — · COMPLETED · sponsor: **University Hospital, Tours** · enrollment: 27 (actual)

## Conditions studied

- Mucopolysaccharidoses

## Interventions

- **OTHER:** Sputum
- **OTHER:** Tracheal aspiration

## Key facts

- **NCT ID:** NCT04112602
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-12
- **Primary completion:** 2020-06-26
- **Final completion:** 2020-06-26
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2022-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04112602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04112602, "Respiratory Cathepsins, Proteases Inhibitors and Glycosaminoglycans (GAG) in Mucopolysaccharidosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04112602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*